Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,185,988
in 8 filings, $4.8M under 10b5-1 plans

Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-12-30 Fairman Jeff VP, Research Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-10-26 Fairman Jeff VP, Research Sale −10,000 $40.00 $400K 286,227
2022-10-11 Fairman Jeff VP, Research Sale −5,000 $25.50 $128K 296,227
2022-09-06 Fairman Jeff VP, Research Sale −4,664 $26.54 $124K 301,563
2022-09-06 Fairman Jeff VP, Research Sale −336 $27.14 $9K 301,227
2022-09-02 Fairman Jeff VP, Research Shares withheld for taxes −519 $26.38 $14K 17,143
2022-08-05 Fairman Jeff VP, Research Sale −5,000 $25.70 $129K 306,227
2022-08-04 Fairman Jeff VP, Research Sale −10,000 $25.50 $255K 311,227
2022-05-20 Fairman Jeff VP, Research Sale −4,112 $25.50 $105K 321,227
2022-05-05 Fairman Jeff VP, Research Sale −888 $25.80 $23K 325,339
2022-04-05 Fairman Jeff VP, Research Sale −5,000 $25.59 $128K 326,227
2022-03-11 Fairman Jeff VP, Research Sale −10,000 $25.50 $255K 331,227
2022-03-02 Fairman Jeff VP, Research Grant or award +6,000 16,629
2022-03-02 Fairman Jeff VP, Research Grant or award · Stock Option (right to buy) +33,000 33,000

Page 1 of 1 · 14 trades